High expression of either SIN3A or SIN3B correlated with longer relapse-free survival in all breast cancers (hazard ratios = 0.58 and 0.49; logrank P = 7.8e-10 and < 1e-16 respectively for SIN3A and SIN3B) (Figure 5A, 5B). Here, SIN3A is linked to breast cancer.